| Literature DB >> 30416535 |
Leslee Sprague1,1, Lynne Braidwood2,2, Joe Conner2,2, Kevin A Cassady3,4,3,4, Fabian Benencia5,5, Timothy P Cripe1,4,1,4.
Abstract
Oncolytic viruses (OVs) do more than simply infect and kill host cells. The accepted mechanism of action for OVs consists of a primary lytic phase and a subsequent antitumor and antiviral immune response. However, not all cells are subject to the direct effects of OV therapy, and it is becoming clear that OVs can also impact uninfected cells in the periphery. This review discusses the effects of OVs on uninfected neighboring cells, so-called bystander effects, and implications for OV therapies alone or in combination with other standard of care chemotherapy.Keywords: bystander effects; chemotherapy; cytokines; inflammation; oncolytic virus
Year: 2018 PMID: 30416535 PMCID: PMC6219440 DOI: 10.2217/fvl-2018-0068
Source DB: PubMed Journal: Future Virol ISSN: 1746-0794 Impact factor: 1.831